SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-064197
Filing Date
2023-05-24
Accepted
2023-05-24 17:25:42
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2316616-1_424b5.htm 424B5 305137
2 GRAPHIC tm2310116d1_s3img01.jpg GRAPHIC 14145
3 GRAPHIC tm2316616d1_424b3img001.jpg GRAPHIC 6697
4 GRAPHIC tm2316616d1_424b3img002.jpg GRAPHIC 6872
  Complete submission text file 0001104659-23-064197.txt   344764
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270843 | Film No.: 23955170
SIC: 2834 Pharmaceutical Preparations